Efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder

Author： Kamath Jayesh DeMartinis Nicholas Handratta Venkatesh

ISSN： 1479-6708

Source： Future Neurology, Vol.2, Iss.4, 2007-07, pp. : 361-371

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Overview of Short-Term and Long-Term Safety of Brexpiprazole in Patients with Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

Current Psychiatry Reviews, Vol. 12, Iss. 3, 2016-12 ,pp. : 278-290

Bentham Science Publishers

Access to resources Recommend Favorite

Anticonvulsants in the Treatment of Major Depressive Disorder: An Overview

By Vigo Daniel Baldessarini Ross

Harvard Review of Psychiatry, Vol. 17, Iss. 4, 2009-08 ,pp. : 231-241

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Escitalopram in the Long-term Treatment of Major Depressive Disorder

By Wade Alan Despiegel Nicolas Heldbo Reines Elin

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 18, Iss. 2, 2006-05 ,pp. : 83-89

Informa Healthcare

Access to resources Recommend Favorite

The bipolar diathesis of treatment-resistant major depressive disorder

By Woo Young Sup Chae Jeong-ho Jun Tae-youn Kim Kwang-soo Bahk Won-myong

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 2, 2008-06 ,pp. : 142-146

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Efficacy of Adjunctive Brexpiprazole in Patients with Major Depressive Disorder: A Clinical Overview

Current Psychiatry Reviews, Vol. 12, Iss. 3, 2016-12 ,pp. : 291-301

Bentham Science Publishers

Access to resources Recommend Favorite